Logo
x

Search

Subscribe Now

psoriasis

Galapagos Reports Results of GLPG3667 in P-Ib Study for the Treatment of Psoriasis

Galapagos Reports Results of GLPG3667 in P-Ib Study for the Treatment of Psoriasis

  • July 15, 2021
Dermavant Presents Results of Tapinarof in Two P-III Trials for the Treatment of Psoriasis at AAD2021

Dermavant Presents Results of Tapinarof in Two P-III Trials for the Treatment of Psoriasis at AAD2021

  • April 26, 2021
UCB Reports Results of Bimekizumab in P-III BE SURE Study for Moderate-to-Severe Psoriasis

UCB Reports Results of Bimekizumab in P-III BE SURE Study for Moderate-to-Severe Psoriasis

  • November 2, 2020
Galapagos Reports First Patients Dosing with GLPG3970 (Toledo Compound) for Psoriasis

Galapagos Reports First Patients Dosing with GLPG3970 (Toledo Compound) for Psoriasis

  • September 30, 2020
Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)

Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)

  • September 4, 2020
Cadila Launches Cadalimab (biosimilar- adalimumab) in India

Cadila Launches Cadalimab (biosimilar- adalimumab) in India

  • August 31, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.